Roy was Senior Vice President of Global Clinical Development, Research Laboratories at Merck, and Senior Vice President of Oncology, Inflammation and Respiratory Therapeutics at Gilead Sciences. Roy Baynes joined Travere Therapeutics in 2025.
Roy Baynes is currently
Create your alert
to follow the career of Roy Baynes.
Roy Baynes has a PhD in Medicine from University of Witwatersrand in Johannesburg.
Do you need to know more about Roy Baynes? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.